Fred Alger Management’s GeneDx Holdings WGS Stock Holding History

Fred Alger Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.45M	Sell	108,527 -94,244	-46%	-$5.36M	0.02%	202
2026 Q1	$13M	Sell	202,771 -63,865	-24%	-$5.82M	0.06%	144
2025 Q4	$34.7M	Sell	266,636 -90,666	-25%	-$12.4M	0.14%	86
2025 Q3	$38.5M	Sell	357,302 -463,221	-56%	-$50.5M	0.15%	76
2025 Q2	$75.7M	Buy	820,523 +263,505	+47%	+$20.7M	0.34%	41
2025 Q1	$49.3M	Buy	557,018 +10,964	+2%	+$951K	0.28%	52
2024 Q4	$42M	Buy	546,054 +151,824	+39%	+$10.6M	0.2%	79
2024 Q3	$16.7M	Buy	+394,230	New	+$13.3M	0.08%	143

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Fred Alger Management's WGS Position: Q2 2026 in Review

Fred Alger Management reduced its GeneDx Holdings (WGS) stake by 46% in Q2 2026, selling an estimated $5.36M and leaving 108,527 shares worth $7.45M. The position accounts for 0.02% of the portfolio, ranked #202.

Fred Alger Management first reported a position in WGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $75.7M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Fred Alger Management held 108,527 shares of GeneDx Holdings worth $7.45M as of Q2 2026.
Fred Alger Management sold 94,244 GeneDx Holdings shares in Q2 2026, an estimated $5.36M.
GeneDx Holdings made up 0.02% of Fred Alger Management's portfolio in Q2 2026, its #202 holding.
Fred Alger Management first reported a position in GeneDx Holdings in Q3 2024 and has held it in 8 quarters since.
Fred Alger Management's GeneDx Holdings position peaked at $75.7M in Q2 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.